Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

146 results
Display

Korean Medication Algorithm Project for Bipolar Disorder 2022: Rapid Cycling

Jeong JH, Bahk WM, Woo YS, Yoon BH, Seo JS, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Park SY, Sohn I, Kim MD, Jung MH, Jon DI

Objectives This study revised the Korean Medication Algorithm Project for Bipolar Disorder 2018 for rapid cycling. Methods Questionnaires to survey the expert opinion of medication for rapid cycling were completed by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents

Yang CM, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Kim W, Lee JG, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH, Shim SH

Objectives The objective of this study was to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2022: children and adolescents. Methods We performed a survey, using a questionnaire comprising...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy

Lee JG, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Kim W, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH

Objectives In this study, we investigated and organized the maintenance-treatment strategies for Bipolar I and II disorders outlined in The Korean Medication Algorithm Project for Bipolar disorder 2022 (KMAP-BP 2022). Methods...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea

Seo JC, Jon DI, Shim SH, Sung HM, Woo YS, Hong J, Park S, Seo JS, Bahk WM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers

Lee JG, Woo YS, Park SW, Seog DH, Seo MK, Bahk WM

Bipolar disorder is a mental illness that causes extreme mood swings and has a chronic course. However, the mechanism by which mood episodes with completely opposite characteristics appear repeatedly, or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Depressive Episode

Seo JS, Woo YS, Bahk WM, Jeong JH, Yoon BH, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD

Objectives After the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was developed in 2002, its fifth revision was completed in 2022 to reflect the recent rapid developments and research...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Overview

Kim W, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH

Objectives The pharmacotherapy of bipolar disorder is complex. A treatment guideline or algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Willingness of Enduring Drug Side Effects in the Patients of Depressive Disorders: From the Results of Korean Nationwide Patients’ Perspectives Survey Study

Ko M, Song HR, Kim SY, Jung YE, Kim W, Seo JS, Sohn I, Lee K, Lee JH, Chung SK, Lee SY, Hong JW, Yoon BH, Woo YS, Bahk WM

Objectives There has been increased use of medications in treating depressive disorders. Nowadays, patient value is an important part of prescribing medications. This study examines depressive patients’ perspectives on the side...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial

Shim Sh, Woo YS, Kim JS, Heo IS, Yoon Hj, Sung HM, Lee J, Bahk WM

Objective: This study aimed to compare the efficacy and safety of atomoxetine (ATX) and OROS methylphenidate (MPH) as adjunctive to selective serotonin reuptake inhibitors (SSRIs) in adults with attention-deficit hyperactivity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea

Seo JC, Jon DI, Shim SH, Sung HM, Woo YS, Hong J, Park S, Seo JS, Bahk WM

Objective: This study investigated the prevalence and comorbidities of attention deficit hyperactivity disorder (ADHD) among adults and children/adolescents in Korea. Methods: This study used data from the Korea Health Insurance Review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (VI): Non-Pharmacological Biological Treatments

Jeong JH, Woo YS, Bahk WM, Wang SM, Seo JS, Park YM, Kim W, Shim SH, Lee JG, Jang SH, Yang CM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder 2021 (KMAP-DD 2021) was made to update new researches and data. This study focused on non-pharmacological biological treatments. Methods Ninety-seven psychiatrists with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (V): Antidepressant Choices According to Safety, Adverse Effect, Comorbid Physical Illnesses and Clinical Definition of Treatment Resistant Depression

Jung MH, Lee JG, Bahk WM, Woo YS, Wang SM, Jeong JH, Kim W, Shim SH, Seo JS, Jang SH, Yang CM, Park YM, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives To revise Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAPDD 2017) guidelines by revising antidepressant choices based on their safety, adverse effects, comorbid physical illnesses, and the clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (IV): Female and Elderly

Wang SM, Bahk WM, Woo YS, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives An expert consensus guideline for the treatment of depressive disorder, the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD), was first established in 2002 and updated in 2017. To...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary

Seo JS, Bahk WM, Woo YS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objective: In the 19 years since the Korean College of Neuropsychopharmacology and the Korean Society for Affective Disorders developed the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) in 2002,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (III): Child and Adolescent

Yang CM, Shim SH, Bahk WM, Woo YS, Jeong JH, Wang SM, Kim W, Seo JS, Lee JG, Park YM, Jang SH, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder 2021 (KMAP-DD 2021) was a revision of previous works. The main purpose of the current study was to amend guidelines for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (II): The Subtypes of Depression

Park YM, Seo JS, Woo YS, Bahk WM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Wang SM, Jung MH, Sung HM, Choo LH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) was developed in 2002 and revised in 2006, 2012, 2017. In 2021, the fifth edition was published. This edition reflected new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (I): Treatment Strategies for Major Depressive Episode

Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) is a consensus-based medication guideline. To reflect advances in pharmacotherapy for depressive disorders, we have undertaken a fourth revision of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study

Chang S, Woo YS, Wang SM, Lim HK, Bahk WM

Objective: The aim of the present study is to identify the factors that affect retention in outpatients with psychiatric disorders as indicators of treatment adherence, including Minnesota Multiphasic Personality Inventory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis

Wang SM, Kim NY, Na HR, Lim HK, Woo YS, Pae CU, Bahk WM

Objective: We performed a meta-analysis of randomized double-blinded placebo controlled trials (DB-RCTs) to investigate efficacy and safety of intranasal esketamine in treating major depressive disorder (MDD) including treatment resistant depression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder

Shim Sh, Kim YK, Hwangbo Y, Yoon Hj, Kim JS, Lee YJ, Woo YS, Bahk WM

Objective: There are animal models associating dopamine dysfunction with behavioral impairments that model attention deficit hyperactivity disorder (ADHD). Erythropoietin (EPO) has trophic effects on dopaminergic neurons. The aim of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr